ATryn
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ATryn, covering 2019-07-02 to 2021-08-31. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis [Phase 2]